Analysts were expecting Luminex Corporation (LMNX) [Chart - News - Analysis] to report earnings of $0.07 for last quarter, but LMNX missed expectations with actual earnings of $-0.01---8 cents below the consensus estimate. LMNX also issued earnings guidance for next quarter that is in line with current analyst expectations.

If you compare last quarter's earnings to the $0.09 the company made per share during the same quarter a year ago, you can see that LMNX’s earnings are down this year.

{loadposition link_newslink1}

Also, if you compare LMNX's 24.38% projected earnings-per-share (EPS) growth rate for the next five years with the projected EPS growth rate of 13.25% for the Medical Instruments & Supplies industry as a whole during that same time frame, you can see that analysts expect LMNX to outperform the industry in the future---which is a good sign for the stock.

Drilling down a little deeper into the Medical Instruments & Supplies industry, you can see how analysts believe LMNX will stack up against some of the other stocks in the industry, like Covidien plc (COV) [Chart - News - Analysis] and Baxter International Inc. (BAX) [Chart - News - Analysis], in the future. Analysts believe COV's earnings are going to grow at a rate of 10.77% while BAX's earnings are going to grow at a rate of 11.83%.

Earnings season can be a volatile time in the stock market. Check out these videos and articles to be better prepared to take advantage of the large price moves that tend to accompany earnings announcements.

- Earnings Season is Here - Find Out How to Trade It

- Using Options to Trade Earnings

- Understanding Stock Analyst Research and Recommendations

{loadposition link_nowtime}

{loadposition followus}